MYRIAD GENETICS INC (MYGN) Corporate Subsidiaries
MYRIAD GENETICS INC (MYGN) is a publicly traded company on the Nasdaq, categorized under SIC 2835 (In Vitro & In Vivo Diagnostic Substances). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MYGN
CIK: 899923
Exchange: Nasdaq
SIC 2835: In Vitro & In Vivo Diagnostic Substances
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 6/30/2017 12:00:00 AM
Lead Engagement PartnerRemco Bartman
Audit LocationSalt Lake City, Utah, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-09 | 2026-10-06 | 8-K | 0000899923-26-000084 | View SEC Doc Filr Page |
| 4 | 2026-09-22 | 2026-09-21 | FORM 4 | 0002082246-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-16 | FORM 4 | 0002065630-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-16 | FORM 4 | 0001931406-26-000007 | View SEC Doc Filr Page |
| 3 | 2026-09-17 | 2026-09-16 | FORM 3 | 0001931406-26-000005 | View SEC Doc Filr Page |
| 8-K | 2026-09-16 | 2026-09-15 | 8-K | 0000899923-26-000079 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-03 | FORM 4 | 0001914879-26-000004 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-04 | — | SCHEDULE 13G Filing | 0002052113-26-000835 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-16 | FORM 4 | 0002082246-26-000008 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000905148-26-003766 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0000902664-26-003504 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0000093751-26-000498 | View SEC Doc Filr Page |
| 10-Q | 2026-07-31 | 2026-06-30 | 10-Q | 0000899923-26-000072 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-30 | 8-K | 0000899923-26-000070 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-23 | FORM 4 | 0001628280-26-044911 | View SEC Doc Filr Page |
| 8-K | 2026-06-23 | 2026-06-17 | 8-K | 0000899923-26-000062 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | FORM 4 | 0001738340-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | FORM 4 | 0002065630-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-08 | FORM 4 | 0001824720-26-000004 | View SEC Doc Filr Page |
| 144 | 2026-06-08 | — | 144 Filing | 0001959173-26-004408 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | FORM 4 | 0001628280-26-041258 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | FORM 4 | 0001788981-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | FORM 4 | 0002024613-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | FORM 4 | 0001471518-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | FORM 4 | 0001379372-26-000002 | View SEC Doc Filr Page |